Search results
Results From The WOW.Com Content Network
Fibrocystic breast changes is a condition of the breasts where there may be pain, breast cysts, and breast masses. [1] The breasts may be described as "lumpy" or "doughy". [ 3 ] Symptoms may worsen during certain parts of the menstrual cycle due to hormonal stimulation. [ 1 ]
The periareolar glands of Montgomery in the breast are also called Montgomery tubercles or Morgagni tubercles. These periareolar glands are small, papular tissue projections at the edge of the areola (nipple).Obstruction of the Montgomery tubercles may result in an acute inflammation, a clear or light brownish fluid may drain out of the areola (nipple discharge), and an subareolar mass may ...
Download QR code; Print/export Download as PDF; ... diseases outlined within the ICD-10 codes N60-N64 within Chapter XIV: Diseases of the genitourinary system should ...
Breast atrophy is the normal or spontaneous atrophy or shrinkage of the breasts. [1]Breast atrophy commonly occurs in women during menopause when estrogen levels decrease. [2] [3] [4] It can also be caused by hypoestrogenism and/or hyperandrogenism in women in general, [1] such as in antiestrogen treatment for breast cancer, in polycystic ovary syndrome (PCOS), [5] [6] and in malnutrition such ...
A breast mass, also known as a breast lump, is a localized swelling that feels different from the surrounding tissue. [1] Breast pain , nipple discharge , or skin changes may be present. [ 1 ] Concerning findings include masses that are hard, do not move easily, are of an irregular shape, or are firmly attached to surrounding tissue.
Worldwide, breast cancer is the leading type of cancer in women, accounting for 25% of all cases. [5] It is most common in women over age 50. Signs of breast cancer may include a lump in the breast, a change in breast shape, dimpling of the skin, fluid coming from the nipple, a newly inverted nipple, or a red or scaly patch of skin. [6]
Based on her own family history of breast cancer and her breast density, 10 years ago, Berg said that she determined for herself that she had a 19.7% lifetime risk of developing the disease.
The ICD-10 Clinical Modification (ICD-10-CM) is a set of diagnosis codes used in the United States of America. [1] It was developed by a component of the U.S. Department of Health and Human services, [ 2 ] as an adaption of the ICD-10 with authorization from the World Health Organization .